Positive Clinical Results For AlloSource’s AlloSkin Announced  |  August 6, 2015

PrintAlloSource®  announced positive clinical results for the use of AlloSkin™ to help heal diabetic foot ulcers, venous leg ulcers or surgical/traumatic wounds.

The peer-reviewed, retrospective study, “Human Skin Allograft for Patients with Diabetic Foot Ulcers, Venous Leg Ulcers, or Surgical/Traumatic Wounds: A Retrospective, Descriptive Study,” was conducted at wound clinics in the Inova Health System and published in Ostomy Wound Management.

Dr. Eric Desman was the principal investigator for this study, which included 36 patients and is the first identified study of very large chronic wounds treated with human skin allografts. The mean wound size in the study was 19.4 cm2.

Continue reading about this study here.

Comments Off on Positive Clinical Results For AlloSource’s AlloSkin Announced

Get our newsletter